Objective: Shiitake mushrooms () are an edible fungus, initially grown in Japan and China that are increasingly marketed in Europe. We previously presented 15 shiitake dermatitis cases reported to Poison Control Centres (PCCs) in France from January 2000 to December 2013. The aim of this study was to describe changes in the number of shiitake dermatitis cases since 2014, and to better describe the clinical characteristics and risk factors of this reaction.
View Article and Find Full Text PDFAims: The risk for drug-drug interactions (DDIs) associated with antiseizure drugs (ASDs) used to manage status epilepticus (SE) patients in the intensive care unit (ICU) has been poorly investigated. We aimed to quantify and describe those potential DDIs and determine SE patient risk profiles.
Methods: We conducted an observational bi-centric cohort study including all SE patients admitted to the ICU in the period 2016-2020.
Methods: We conducted a retrospective review of spp. snakebite cases registered by the PCC of Bordeaux, France, between January 1, 2018, and December 31, 2020, evaluating the agreement between VipGrade assessments, toxicologists' assessments, and current guidelines.
Results: 133 patients with snakebites were included.